AI assistant
Sending…
RESMED INC — Director's Dealing 2016
Nov 15, 2016
30071_dirs_2016-11-15_c7d64dfb-87e2-4356-a50d-14959052ee4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-11-11
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-11 | ResMed Common Stock | F | 3576 | $59.85 | Disposed | 27946 | Direct |
| 2016-11-11 | ResMed Common Stock | F | 4082 | $59.85 | Disposed | 23864 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 78178 | Indirect |
Footnotes
F1: Includes 219 shares of ResMed stock purchased on 4/30/2016, through the ResMed Employee Stock Purchase Plan.
F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/13/2013.
F3: Includes 218 shares of ResMed stock purchased on 10/31/2016, through the ResMed Employee Stock Purchase Plan.
F4: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29